Kate Quirk, Neuroendocrine Cancer UK Patient Support Coordinator, has just been appointed to the INCA Research Committee, after contributing to the completion of a project to bring wider access to Clinical Trials for Neuroendocrine Cancer patients globally.
INCA (the International Neuroendocrine Cancer Alliance) is the global voice for patients and their carers with a mission to raise awareness for all types of NETS. INCA consistently pushes for scientific advancements with a focus on identified but unmet needs, and provides a platform for global collaboration to address the many challenges NET patients and the medical community face – especially in securing a timely diagnosis and accessing optimal treatment, support and care.
Kate, who completed the year long INCA Research Advocates ‘Bootcamp’ training programme in 2020 said: “It’s a privilege to join this team – my colleagues on the Research Committee work tirelessly to raise awareness and improve access to the latest research and clinical trials available globally. There’s so much going on in the background to keep Neuroendocrine Cancer at the forefront of international developments and I’m delighted to contribute. Sooner, rather than later, we must see a breakthrough.”
Read Kate’s patient perspective of living with lung neuroendocrine cancer and how she is using her experience to help others here